Showing results (1-10 of 176) with videos related to
Sort By:
Pageof 18
Transfusion|October 15, 2013
Pathogen inactivation and removal methods for plasma-derived clotting factor concentratesRobert Klamroth, Albrecht Gröner, Toby L SimonBiotechnology Progress|November 20, 2023
Integration of Planova filters in manufacturing processes of biologicals improve the virus safety effectively: A review of publicly available dataAlbrecht GrönerTransfusion|March 15, 2012
Pathogen safety of human C1 esterase inhibitor concentrateAlbrecht Gröner, Thomas Nowak, Wolfram SchäferTransfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|October 24, 2003
Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert P) in hereditary angioedema: a review. jean.de.serres@aventis.comJean De Serres, Albrecht Gröner, Jürgen LindnerHamostaseologie|November 26, 2016
A new era of treatment for patients with haemophilia A?Robert KlamrothHamostaseologie|April 30, 2024
Current Topics from the Revised German S2k Guideline on Diagnosis and Treatment of Venous ThromboembolismBirgit Linnemann, Robert KlamrothPatient Preference and Adherence|May 6, 2020
The Patient Experience of Gene Therapy for Hemophilia: Qualitative Interviews with Trial PatientsWolfgang Miesbach, Robert KlamrothThe Journal of General Virology|December 3, 2010
Comparison of the level, distribution and form of disease-associated prion protein in variant and sporadic Creutzfeldt-Jakob diseased brain using conformation-dependent immunoassay and Western blotYoung Pyo Choi, Albrecht Gröner, James W Ironside, et al.Brain Pathology (Zurich, Switzerland)|October 30, 2010
Correlation of polydispersed prion protein and characteristic pathology in the thalamus in variant Creutzfeldt-Jakob disease: implication of small oligomeric speciesYoung Pyo Choi, Albrecht Gröner, James W Ironside, et al.Pageof 18